최대 4개 패밀리를 선택해 비교합니다.

보내기

PCSK9 inhibitor chemical & modality series

PCSK9 / LDL-C

  • 화합물 9
  • 관계 28
  • SMILES 9/9
  • Drug: 5
  • Derivative: 3
  • Scaffold: 1

Oral macrocyclic peptide PCSK9i (enlicitide / Lipfendra) mapped with injectable mAb (evolocumab, alirocumab) and siRNA (inclisiran) class peers for LDL-C lowering.

맵 열기 →